Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
Mes dernières consult.
Most popular
Real-time Quote. Real-time Tradegate - 10/17 11:52:29 am
118.126 EUR   -1.23%
10:18a BAYER : foundations bring tech pioneers physicians and social entrep..
10/14DJBAYER : Unloads Assets to Aid Deal -- WSJ
10/13 BASF CEO says to look at more seed M&A after Bayer deal
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Strengths
  • The group's high margin levels account for strong profits.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The tendency within the weekly time frame is positive above the technical support level at 104.25 EUR
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at EUR 122.8.
  • Technically, the stock approaches a strong medium-term resistance at EUR 123.3.
  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
BAYER19.19%116 409
JOHNSON & JOHNSON18.42%365 346
NOVARTIS13.23%226 956
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751
AMGEN25.17%132 728
SANOFI8.71%125 652
CELGENE CORPORATION17.89%106 955
BRISTOL-MYERS SQUIBB COMPAN..11.72%104 381
GLAXOSMITHKLINE-2.94%99 014
NOVO NORDISK A/S16.92%97 056
ABBOTT LABORATORIES42.28%94 917
ELI LILLY AND COMPANY17.68%94 630
ASTRAZENECA15.54%86 688
ALLERGAN PLC-2.14%66 330
More Results
Financials (€)
Sales 2017 48 368 M
EBIT 2017 9 231 M
Net income 2017 5 396 M
Debt 2017 12 235 M
Yield 2017 2,32%
P/E ratio 2017 19,67
P/E ratio 2018 17,76
EV / Sales 2017 2,30x
EV / Sales 2018 2,19x
Capitalization 98 903 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart BAYER
Duration : Period : Day
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Duration : Period : Week
Bayer Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders